In this study, among the 26 RCC cases, PD-L1-positive rate in tumor cells was significantly higher in specimens with 4 somatically mutated genes, including CSPG4, DNAH11, INADL and TMPRSS13, than in samples without those (P < 0.05). This evidence concerns the gene DNAH11 and neoplasm.